Metronidazole
- Generic Name
- Metronidazole
- Brand Names
- Flagyl, Flagystatin, Likmez, Metrocream, Metrogel, Metrolotion, Nidagel, Noritate, Nuvessa, Pylera, Rosadan, Vandazole
- Drug Type
- Small Molecule
- Chemical Formula
- C6H9N3O3
- CAS Number
- 443-48-1
- Unique Ingredient Identifier
- 140QMO216E
- Background
Metronidazole is a commonly used antibiotic, belonging to the nitroimidazole class of antibiotics. It is frequently used to treat gastrointestinal infections as well as trichomoniasis and giardiasis, and amebiasis which are parasitic infections. Metronidazole has been used as an antibiotic for several decades, with added antiparasitic properties that set it ...
- Indication
Metronidazole is indicated for the treatment of confirmed trichomoniasis caused by Trichomonas vaginalis (except for in the first trimester of pregnancy) and the patient's sexual partners, bacterial vaginosis, certain types of amebiasis, and various anaerobic infections. The above anaerobic infections may occur on the skin and skin structures, the abdomen, t...
- Associated Conditions
- Abscess Brain, Abscess, Intra-Abdominal, Anaerobic Bacterial Infection, Bacterial Endocarditis, Bacterial Peritonitis, Bacterial Septicemia, Bacterial Vaginosis (BV), Balantidiasis, Bone and Joint Infections, Central Nervous System Bacterial Infections, Empyema, Endometritis, Endomyometritis, Facial Rosacea, Giardiasis, Gynecological Infection, Helicobacter Pylori Infection, Inflammatory Papule, Inflammatory pustules, Liver Abscess, Amebic, Lower respiratory tract infection bacterial, Lung Abscess, Meningitis, Mixed Vaginal Infections, Mixed Vaginal Infections caused by Trichomonas Vaginalis, candida albicans, Periodontitis, Pneumonia, Postoperative Infections, Pouchitis, Skin and skin structure infections, Tetanus, Trichomonas Vaginitis, Tubo-ovarian abscess, Vaginal Candidiasis, Vaginitis Trichomonal, Vulvovaginitis, Acute Intestinal amebiasis, Asymptomatic Trichomoniasis, Entamoeba histolytica, Hepatic abscess, Intra-abdominal bacterial infections, Post-surgical vaginal cuff infection, Refractory Sinusitis, Symptomatic Trichomoniasis
- Associated Therapies
- -
A "Screen and Treat" Helicobacter Pylori Eradication Trial in Adolescents in Three Regions of Chile
- Conditions
- Interventions
- First Posted Date
- 2023-07-03
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Miguel O'Ryan Gallardo
- Target Recruit Count
- 500
- Registration Number
- NCT05926804
- Locations
- 🇨🇱
Universidad de Chile, Santiago, Chile
🇨🇱Universidad de Aysén, Coyhaique, Chile
🇨🇱Universidad de la Frontera, Temuco, Chile
Doxycycline for Helicobacter Pylori Rescue Treatment
- Conditions
- Interventions
- First Posted Date
- 2023-05-25
- Last Posted Date
- 2023-09-25
- Lead Sponsor
- Shanghai Jiao Tong University School of Medicine
- Target Recruit Count
- 368
- Registration Number
- NCT05874570
- Locations
- 🇨🇳
Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, China
Rescue Therapy for Helicobacter Pylori Infection
- Conditions
- Interventions
- First Posted Date
- 2023-05-25
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- Shanghai Jiao Tong University School of Medicine
- Target Recruit Count
- 357
- Registration Number
- NCT05874544
- Locations
- 🇨🇳
Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, China
🇨🇳Shanghai Songjiang District Central Hospital, Shanghai, Shanghai, China
🇨🇳The Second Affiliated Hospital of Zhejiang University school of Medicine, Hangzhou, Zhejiang, China
Standard Versus Prolonged Antibiotic Prophylaxis After Pancreatoduodenectomy (SPARROW)
- First Posted Date
- 2023-03-24
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- Leiden University Medical Center
- Target Recruit Count
- 344
- Registration Number
- NCT05784311
- Locations
- 🇳🇱
Leiden University Medical Center, Leiden, Zuid Holland, Netherlands
🇳🇱Amsterdam University Medical Center, Amsterdam, Netherlands
🇳🇱Amphia Ziekenhuis, Breda, Netherlands
Quintuple Method for Treatment of Multiple Refractory Colorectal Liver Metastases
- First Posted Date
- 2023-03-20
- Last Posted Date
- 2023-03-20
- Lead Sponsor
- Liaoning Tumor Hospital & Institute
- Target Recruit Count
- 100
- Registration Number
- NCT05774964
- Locations
- 🇨🇳
Liaoning Tumor Hospital & Institute, Shenyang, Liaoning, China
Early Blocking Strategy for Metachronous Liver Metastasis of Colorectal Cancer Based on Pre-hepatic CTC Detection
- First Posted Date
- 2023-02-09
- Last Posted Date
- 2023-02-09
- Lead Sponsor
- Liaoning Tumor Hospital & Institute
- Target Recruit Count
- 100
- Registration Number
- NCT05720559
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
- Conditions
- Interventions
- First Posted Date
- 2022-07-18
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Target Recruit Count
- 25
- Registration Number
- NCT05462496
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Surgical Access Combined With Systematically Administered Antibiotics in the Treatment of Peri-implantitis
- Conditions
- Interventions
- First Posted Date
- 2022-07-05
- Last Posted Date
- 2024-07-18
- Lead Sponsor
- University of Guarulhos
- Target Recruit Count
- 89
- Registration Number
- NCT05444218
- Locations
- 🇧🇷
University of Guarulhos, Guarulhos, São Paulo, Brazil
Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment
- First Posted Date
- 2022-02-22
- Last Posted Date
- 2022-03-18
- Lead Sponsor
- Shanghai Zhongshan Hospital
- Target Recruit Count
- 388
- Registration Number
- NCT05250050
- Locations
- 🇨🇳
Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, Shanghai, China
🇨🇳Huashan Hospital, Fudan University, Shanghai, Shanghai, China
🇨🇳Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China
Efficacies of Hybrid and High-dose Dual Therapies for the First-line Anti-H Pylori Treatment
- Conditions
- Interventions
- First Posted Date
- 2021-12-09
- Last Posted Date
- 2022-07-20
- Lead Sponsor
- Chang Gung Memorial Hospital
- Target Recruit Count
- 240
- Registration Number
- NCT05152004
- Locations
- 🇨🇳
Chang Gung Memorial Hospital, Kaohsiung, Taiwan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.